A Randomized Phase 2 Trial Comparing Carfilzomib-Dexamethasone Vs Observation As Maintenance After Induction With Carfilzomib-Cyclophosphamide-Dexamethasone In Salvage Asct In Multiple Myeloma: A Trial By The Nordic Myeloma Study Group

BLOOD(2019)

引用 6|浏览13
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要